Large owner Masters Michael Willingham sold $179,641 worth of shares (306,135 units at $0.59) (SEC Form 4)
$VERO
Medical/Dental Instruments
Health Care
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Venus Concept Inc. [ VERO ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 09/30/2024 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock, $0.0001 par value per share | 09/30/2024 | S | 22,301 | D | $0.6449 | 308,383 | I | By Marlin Fund, Limited Partnership. See footnote(1) | ||
| Common Stock, $0.0001 par value per share | 09/30/2024 | S | 17,715 | D | $0.6449 | 244,965 | I | By Marlin Fund II, Limited Partnership. See footnote(2) | ||
| Common Stock, $0.0001 par value per share | 09/30/2024 | S | 1,619 | D | $0.6449 | 22,383 | I | By Marlin Fund III, Limited Partnership. See footnote(3) | ||
| Common Stock, $0.0001 par value per share | 09/30/2024 | S | 3,327 | D | $0.6449 | 46,009 | I | By Marlin Master Fund Offshore II, LP. See footnote(4) | ||
| Common Stock, $0.0001 par value per share | 09/30/2024 | S | 26,406 | D | $0.6449 | 356,939 | I | By MSS VC SPV LP. See footnote(5) | ||
| Common Stock, $0.0001 par value per share | 10/01/2024 | S | 43,814 | D | $0.5952 | 264,569 | I | By Marlin Fund, Limited Partnership. See footnote(1) | ||
| Common Stock, $0.0001 par value per share | 10/01/2024 | S | 34,804 | D | $0.5952 | 210,161 | I | By Marlin Fund II, Limited Partnership. See footnote(2) | ||
| Common Stock, $0.0001 par value per share | 10/01/2024 | S | 3,180 | D | $0.5952 | 19,203 | I | By Marlin Fund III, Limited Partnership. See footnote(3) | ||
| Common Stock, $0.0001 par value per share | 10/01/2024 | S | 6,537 | D | $0.5952 | 39,472 | I | By Marlin Master Fund Offshore II, LP. See footnote(4) | ||
| Common Stock, $0.0001 par value per share | 10/01/2024 | S | 51,879 | D | $0.5952 | 305,060 | I | By MSS VC SPV LP. See footnote(5) | ||
| Common Stock, $0.0001 par value per share | 10/02/2024 | S | 29,546 | D | $0.5305 | 235,023 | I | By Marlin Fund, Limited Partnership. See footnote(1) | ||
| Common Stock, $0.0001 par value per share | 10/02/2024 | S | 23,470 | D | $0.5305 | 186,691 | I | By Marlin Fund II, Limited Partnership. See footnote(2) | ||
| Common Stock, $0.0001 par value per share | 10/02/2024 | S | 2,144 | D | $0.5305 | 17,059 | I | By Marlin Fund III, Limited Partnership. See footnote(3) | ||
| Common Stock, $0.0001 par value per share | 10/02/2024 | S | 4,408 | D | $0.5305 | 35,064 | I | By Marlin Master Fund Offshore II, LP. See footnote(4) | ||
| Common Stock, $0.0001 par value per share | 10/02/2024 | S | 34,985 | D | $0.5305 | 270,075 | I | By MSS VC SPV LP. See footnote(5) | ||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Explanation of Responses: |
| 1. These securities are held in the account of Marlin Fund, Limited Partnership, a private fund managed by Masters Capital Management, LLC ("MCM"). These securities may be deemed to be beneficially owned by MCM by virtue of its role as the general partner of Marlin Fund, Limited Partnership, and Michael Masters by virtue of his role as the controlling founder and managing member of MCM. |
| 2. These securities are held in the account of Marlin Fund II, Limited Partnership, a private fund managed by MCM. These securities may be deemed to be beneficially owned by MCM by virtue of its role as the general partner of Marlin Fund II, Limited Partnership, and Michael Masters by virtue of his role as the controlling founder and managing member of MCM. |
| 3. These securities are held in the account of Marlin Fund III, Limited Partnership, a private fund managed by MCM. These securities may be deemed to be beneficially owned by MCM by virtue of its role as the general partner of Marlin Fund III, Limited Partnership, and Michael Masters by virtue of his role as the controlling founder and managing member of MCM. |
| 4. These securities are held in the account of Marlin Master Fund Offshore II, LP, a private fund managed by MCM. These securities may be deemed to be beneficially owned by MCM by virtue of its role as the general partner of Marlin Master Fund Offshore II, LP, and Michael Masters by virtue of his role as the controlling founder and managing member of MCM. |
| 5. These securities are held in the account of MSS VC SPV LP, a private fund managed by Masters Special Situations, LLC ("MSS"). These securities may be deemed to be beneficially owned by MSS by virtue of its role as the investment manager of such private fund and as managing member of MSS VC SPV GP, LLC, the general partner of such private fund, and Michael Masters by virtue of his role as the controlling founder of MSS. |
| Remarks: |
| The Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| /s/ Michael Masters | 10/02/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||